Abstract:Background: Colorectal cancer (CRC) is the third most common cancer and the second most common cause of cancer-related mortality worldwide. Mesenchymal-epithelial transition factor (MET) gene participates in multiple tumor biology and shows clinical potential for pharmacological manipulation in tumor treatment. MET amplification has been reported in CRC, but data are very limited. Investigating pathological values of MET in CRC may provide new therapeutic and genetic screening options in future clinical practice. Aim: To determine the pathological significance of MET amplification in CRC and to propose a feasible screening strategy. Methods: A number of 205 newly diagnosed CRC patients undergoing surgical resection without any preoperative therapy at Shenzhen Cancer Hospital of Chinese Academy of Medical Sciences were recruited. All patients were without RAS/RAF mutation or microsatellite instability-high. MET amplification and c-MET protein expression were analyzed using fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC), respectively. Correlations between MET aberration and pathological features were detected using the chi-squared test. Progression free survival (PFS) during the two-year follow-up was detected using the Kaplan-Meier method and log rank test. The results of MET FISH and IHC were compared using one-way ANOVA. Results: Polysomy-induced MET amplification was observed in 14.4% of cases, and focal MET amplification was not detected. Polysomy-induced MET amplification was associated with a higher frequency of lymph node metastasis (LNM) (P < 0.001) and higher tumor budding grade (P = 0.02). In the survival analysis, significant difference was detected between patients with amplified- and non-amplified MET in a two-year follow-up after the first diagnosis (P = 0.001). C-MET scores of 0, 1+, 2+, and 3+ were observed in 1.4%, 24.9%, 54.7%, and 19.0% of tumors, respectively. C-MET overexpression correlated with higher frequency of LNM (P = 0.002), but no significant difference of PFS was detected between patients with different protein levels. In terms of concordance between MET FISH and IHC results, MET copy number showed no difference in c-MET IHC 0/1+ (3.35 ± 0.18), 2+ (3.29 ± 0.11) and 3+ (3.58 ± 0.22) cohorts, and the MET-to-CEP7 ratio showed no difference in three groups (1.09 ± 0.02, 1.10 ± 0.01, and 1.09 ± 0.03). Conclusion: In CRC, focal MET amplification was a rare event. Polysomy-induced MET amplification correlated with adverse pathological characteristics and poor prognosis. IHC was a poor screening tool for MET amplification.

Expression of C-MET, COX-2, MSS and Ki-67 in colorectal cancer and its correlation with the prognosis

Expression of cyclooxygenase 2 in colorectal cancer

[Expression and Significance of Bmi-1 and Ki67 in Colorectal Carcinoma Tissues].

Correlation of Multiple Proteins with Clinic-Pathological Features and Its Prognostic Significance in Colorectal Cancer with Signet-Ring Cell Component.

[Relationship Between the Protein Expression of P53, C-Erbb-2, Vascular Endothelial Growth Factor and CD44 and the Survival Rates of Stage II( Colorectal Cancer Patients Without Radiochemotherapy after Radical Resection].

Prognostic Value of C-Met in Colorectal Cancer:A Metaanalysis

C-Myb and Its Effector COX-2 As an Indicator Associated with Prognosis and Therapeutic Outcome in Colorectal Cancer

Prognostic value of c-Met in colorectal cancer: a meta-analysis.

Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma

Expression and significance of Her-2,P53 and Ki-67 in colorectal cancer

Expression Of Ki-67 And Pakt In Colorectal Cancer Tissues And Their Clinical Significance

Prognostic value and sensitivity to chemotherapy of microsatellite instability in advanced colorectal cancer

Immunohistochemical analysis revealed CD34 and Ki67 protein expression as significant prognostic factors in colorectal cancer

The expressions of COX-2 and VEGF-C in stage Ⅱ and Ⅲ rectal cancer and its association with angiogenesis and prognoses

C-Met As a Molecular Marker for Esophageal Squamous Cell Carcinoma and Its Association with Clinical Outcome

Ccx-Ckr Expression In Colorectal Cancer And Patient Survival

Increased expression of Ki-67 is a poor prognostic marker for colorectal cancer patients: a meta analysis

Expression and prognostic value of epithelial-to-mesenchymal transition and cancer stem cellmarkersin primary lesions and liver metastases of colorectal cancers

Mesenchymal-epithelial transition factor amplification correlates with adverse pathological features and poor clinical outcome in colorectal cancer

Associations Between the Cyclooxygenase‐2 Expression in Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer

EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features